Eli Lilly to Acquire Point Biopharma to Strengthen its Oncology Portfolio
By Shweta Gupta
Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)
Published: 14 Oct-2023
DOI: 10.3833/pdr.v2023.i10.2810 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Expanding its presence in oncology, Eli Lilly has entered into an agreement to acquire Point Biopharma in a deal worth up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS